Toxic epidermal necrolysis: examining a multifaceted enigma.
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003176:Complement C3; D004890:Erythema / Q000209:etiology; D005260:Female; D006801:Humans; D007074:Immunoglobulin G; D008297:Male; D011379:Prognosis; D013203:Staphylococcal Infections / Q000150:complications; D013211:Staphylococcus aureus; D013256:Steroids / Q000627:therapeutic use; D013262:Stevens-Johnson Syndrome / Q000139:chemically induced / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology / Q000473:pathology; D014765:Viral Vaccines / Q000009:adverse effects; D014777:Virus Diseases / Q000150:complications
D000900:Anti-Bacterial Agents; D003176:Complement C3; D007074:Immunoglobulin G; D013256:Steroids; D014765:Viral Vaccines